SEC Filing Summary: AVRA Medical Robotics, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AVRA Medical Robotics, Inc. (the "Company") on September 14, 2021, covering events occurring on September 10, 2021. The Company is incorporated in Florida and identifies as an emerging growth company. The filing addresses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the audit firm.
Material Changes
- Termination of Prior Accountant: The Company ended its engagement with D. Brooks and Associates CPAs, P.A. ("D. Brooks") effective September 10, 2021. D. Brooks was engaged on January 26, 2021, but did not issue any reports on the Company's financial statements during this period.
- Appointment of New Accountant: The Company engaged BF Borgers CPA PC ("BF Borgers") as its new independent registered public accounting firm, effective September 10, 2021.
- Disagreements and Reportable Events: The Company reported no disagreements with D. Brooks regarding accounting principles, financial statement disclosures, or auditing scope. No "reportable events" occurred during the engagement period.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. The primary risk disclosed relates to the transition of audit responsibilities. The Company confirmed that it did not consult with BF Borgers regarding any accounting matters or potential disagreements prior to their engagement.
Investor Verification Checklist
- Verify the status of the Company's most recent audited financial statements, noting that D. Brooks did not issue a report during their engagement.
- Confirm the timeline for the first audit or review report to be issued by the new firm, BF Borgers CPA PC.
- Review the letter from D. Brooks (Exhibit 16.1) filed concurrently to ensure no undisclosed disagreements exist.
- Monitor subsequent filings for the Company's first financial results under the new accounting firm.